About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by PressReach

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
New Study Reveals How Classical Music Could Revolutionize Depression Care
Via PressReach
Exposures Product Safety
Tickers ALZN AXSM BIIB NBIX
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of Next-Generation Treatment for Major Depressive Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Surf Air Mobility Announces Closing of $35.2 Million Mandatory Convertible Security with GEM Global Yield LLC
Via PressReach
Tickers SRFM
Two New Sales for Knightscope’s Emergency Communications
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
E3 Lithium Plans to Construct a Fully Integrated Lithium Demonstration Facility
Via PressReach
Topics Economy Supply Chain
Exposures Supply Chain
Tickers EEMMF TSX-V:ETL
Anthony Milewski Unveils Monthly Newsletter for Mastering Market Speculation
Via PressReach
Huntington Park Police Renews Knightscope Partnership for Sixth Year as Crime Rates Drop
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Surf Air Mobility to Provide Second Quarter 2024 Financial Results on August 14, 2024
Via PressReach
Tickers SRFM
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
Via PressReach
Exposures Product Safety
Tickers ABBV ALZN ITCI TEVA
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder and Alzheimer’s Disease
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Alzheimer’s Disease
Via PressReach
Tickers ALZN
The Future of AI Robotics: Generative AI and RaaS Poised for Rapid Growth
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers C KSCP NVDA SERV
Huntington Park Police Renews Knightscope Contract for 6th Year
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Xcyte Digital Corp. Announces Advanced AI-Powered Captioning and Translation Features
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers AMZN TSX-V:XCYT
Abaxx and MineHub Forge Strategic Partnership to Revolutionize Commodities Markets
Via PressReach
Topics Climate Change Economy
Exposures Climate Supply Chain
Tickers TSX-V:MHUB
School and Transit Clients Expand Knightscope Contracts
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
E3 Lithium Files Clearwater Project NI 43-101 Technical Report
Via PressReach
Tickers EEMMF TSX-V:ETL
University of Texas Expands Emergency Communications
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Knightscope Announces Second Quarter 2024 Town Hall on August 15
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
California Multifamily Community Expands Knightscope Contract
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Xcyte Digital Corp. Announces Strategic Partnership with Pixel Canvas
Via PressReach
Tickers TSX-V:XCYT VZ
Two University Clients Expand Knightscope Contracts
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
California Marketplace Renews Knightscope Contract for 6th Year
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
E3 Lithium Announces Annual Meeting Results and Grant of Stock Options
Via PressReach
Tickers EEMMF TSX-V:ETL
College Adds Knightscope Blue Light Towers for Student Safety
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers ASX:TWR KSCP
LiDAR-Camera Fusion: The Secret to Safer Autonomous Vehicles
Via PressReach
Topics Artificial Intelligence Electric Vehicles
Exposures Artificial Intelligence Electric Vehicles
Tickers INVZ KSCP LAZR MVIS
Knightscope Announces All-New K1 Laser Product
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Protecting Your Money in a Volatile Market: Expert Advice
Via PressReach
Topics Bonds
Exposures Debt Markets
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.